Project Grant R25DA064772
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $707,108 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to The Regents of the University of California, Berkeley (UC Berkeley) for the "International Development Project (IDP): An International Collaboration for the Standardized Study of Experience-Dependent Brain and Behavioral Development". The project aims to study the effects of various forms of...
- This $600,580 federal project grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) will fund a 3-week summer workshop to equip graduate students and junior researchers with knowledge and skills to conduct reproducible analysis of brain imaging genomics data. The primary focus will be on learning best practices for estimating associations between genetic variants and brain structure/function, and their implications for cognitive function...
- This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $613,107.00 to the Massachusetts Institute of Technology (MIT) from January 1, 2025 to November 30, 2029. The project aims to apply a novel brain imaging method called BLUSH to study brain-wide neuroplasticity and its relationship to neural activity, structural changes, and individual behavioral variability. Specific research objectives include:...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $407,382 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Texas at Austin (UT Austin). The grant, titled "REPRESENTATIONAL GEOMETRY: EVALUATING BRAIN-COMPUTATIONAL MODELS WITH NEURAL ACTIVITY DATA", will fund a collaboration between theorists and experimentalists to develop rigorous methods for evaluating and comparing complex...
- This federal Project Grant award of $811,112 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research on the network and circuit dynamics underlying dopaminergic control of sudden insight learning. The principal investigator and research team at the University of California, San Francisco (UCSF) will use a combination of large-scale two-photon calcium imaging, high-density electrophysiology, dopamine sensor fiber...
- This Project Grant award from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, under the Drug Use and Addiction Research Programs (CFDA 93.279), provides funding of $196,560.00 to the University of Michigan to conduct research on the neural responses to reward and threat in individuals with a history of childhood adversity. The research aims to identify predictive neurosignatures that can inform novel targeted intervention strategies for substance use...
- The federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $439,180 to The Johns Hopkins University to investigate the role of dopaminergic neuron-glial interactions in the striatum in the context of HIV infection and substance use disorders. The research aims to deconvolute the complex interplay between HIV, methamphetamine use, and alterations in dopamine signaling pathways, which can contribute...
- This federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $611,254 to fund the "Brains, Minds and Machine Advanced Research Training Course" at the Marine Biological Laboratory (MBL) in Woods Hole, MA. The goal of this in-person course is to cultivate a community of leaders with deep expertise in neuroscience, cognitive science, and computer science to advance the scientific...
- This federal Project Grant award of $201,250 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports research on the synaptic organization of cholinergic interneurons in the nucleus accumbens region of the brain. The study, conducted by New York University (NYU), aims to characterize the diverse excitatory and inhibitory inputs that contact these interneurons and influence their firing patterns. The research combines...
- This National Science Foundation (NSF) Project Grant under the Social, Behavioral, and Economic Sciences program (CFDA 47.075) awarded Northeastern University $532,152 on May 1, 2025 to conduct research on the neurocognitive development of learning in adolescents. The project aims to investigate the cognitive and brain mechanisms related to learning from experience, and how these change from childhood to adolescence and young adulthood. Using behavioral, computational, and neuroimaging...
The federal Project Grant award of $269,200 from the National Institute on Drug Abuse (NIDA), part of the Drug Use and Addiction Research Programs (CFDA 93.279), will fund the "The Changing Brain: Engaging Montana's Students with Neuroplasticity Research and Career Pathways" project. Led by Principal Investigators Dr. Rachel Severson and Alex Sobin at the University of Montana, this 5-year project aims to: 1) Foster college and career readiness skills and near-peer role model opportunities for a thriving research and healthcare workforce in Montana; 2) Promote public understanding of neuroplasticity, neural injury research, and related clinical careers; and 3) Develop a replicable model for embedding accessible, locally relevant P-12 neuroscience, psychology, and biomedical programming in community hubs. Key project deliverables include a high school "explainer" program and engagement activities to educate P-12 students and the public on neuroplasticity research and healthcare careers in Montana.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $269.2k | 9/10/25 |